The yeast Smf1p Nramp manganese transporter is posttranslationally regulated by environmental manganese. Smf1p is stabilized at the cell surface with manganese starvation, but is largely degraded in the vacuole with physiological manganese through a mechanism involving the Rsp5p adaptor complex Bsd2p/Tre1p/Tre2p. We now describe an additional level of Smf1p regulation that occurs with toxicity from manganese, but not other essential metals. This regulation is largely Smf1p-specific. As with physiological manganese, toxic manganese triggers vacuolar degradation of Smf1p by trafficking through the multivesicular body. However, regulation by toxic manganese does not involve Bsd2p/Tre1p/Tre2p. Toxic manganese triggers both endocytosis of cell surface Smf1p and vacuolar targeting of intracellular Smf1p through the exocytic pathway. Notably, the kinetics of vacuolar targeting for Smf1p are relatively slow with toxic manganese and require prolonged exposures to the metal. Down-regulation of Smf1p by toxic manganese does not require transport activity of Smf1p, whereas such transport activity is needed for Smf1p regulation by manganese starvation. Furthermore, the responses to manganese starvation and manganese toxicity involve separate cellular compartments. We provide evidence that manganese starvation is sensed within the lumen of the secretory pathway, whereas manganese toxicity is sensed within an extra-Golgi/cytosolic compartment of the cell.
INTRODUCTION
Metals that are both essential and potentially toxic pose a challenge to cells in that sufficient quantities must be acquired in times of metal starvation, whereas hyperaccumulation must be minimized in times of metal surplus. To help meet this challenge, the levels and/or cellular localization of metal transporters are often regulated in response to changes in metal exposures. In studies that have been conducted in yeast, transporters for zinc, copper, and iron are all induced at the level of transcription by metal responsive transcription factors (Jungmann et al., 1993; Yamaguchi-Iwai et al., 1996; Iwai et al., 1997; Zhao and Eide, 1997; Dancis, 1998 ). Yet thus far, no transcriptional regulation has been described for transporters of manganese. Instead, the major manganese transporters of yeast, Smf1p and Smf2p, are regulated at the posttranslational level.
Smf1p and Smf2p are members of a well-conserved family of Nramp metal transporters that from bacteria to humans are involved in the uptake and distribution of iron, manganese, and other divalent metals (Cellier et al., 1995; Gunshin et al., 1997; Thomine et al., 2000) . Although Smf1p and Smf2p are both manganese transporters in yeast, they are not redundant in function. Smf2p is largely responsible for the activation of manganese enzymes in the cell (Luk et al., 2005) , whereas Smf1p is more critical for oxidative stress protection by supplying the cell with critical manganese antioxidants (Reddi et al., 2009) . With normal physiological levels of manganese, a large fraction of Smf1p and Smf2p are subject to rapid turnover by degradation in the vacuole (Liu and Culotta, 1999b; Portnoy et al., 2000) . This continual degradation of Smf1p and Smf2p maintains these transporters at a low steady-state level that is sufficient for essential manganese acquisition but prohibits excess transport of other toxic metals (Liu et al., 1997) .
The vacuolar degradation of Smf1p and Smf2p during physiological manganese has been well characterized. In the secretory pathway, the bulk of newly synthesized Smf1p and Smf2p are recognized by Tre1p/Tre2p and Bsd2p, which triggers ubiquitination of the transporters via Rsp5p. Ubiquitinated Smf1p and Smf2p then enter the multivesicular body (MVB) pathway for delivery to the vacuolar lumen for degradation (Liu et al., 1997; Liu and Culotta, 1999b; Portnoy et al., 2000; Eguez et al., 2004; Hettema et al., 2004; Stimpson et al., 2006; Sullivan et al., 2007) . Yet during manganese starvation, this down-regulation of Smf1p and Smf2p is abrogated. The transporter polypeptides fail to be recognized by Tre1p/Tre2p and Bsd2p and rather than vacuolar targeting, the bulk of Smf1p and Smf2p relocate to the cell surface and intracellular vesicles to optimize manganese uptake and distribution (Liu and Culotta, 1999b; Luk and Culotta, 2001; Sullivan et al., 2007) . The mechanism for the switch in Smf1p and Smf2p localization is currently unknown, but has been proposed to involve manganese binding directly to the transporters (Liu and Culotta, 1999a; Sullivan et al., 2007) . In addition to up-regulation by metal starvation, many metal transporters are down-regulated in response to metal toxicity. For example, yeast transporters for zinc, copper, and iron are turned over when cells are challenged with high doses of these metal ions (Gitan and Eide, 2000a; Gitan et al., 2003; Petris et al., 2003; Felice et al., 2005; Liu et al., 2007; Strochlic et al., 2008) . In all three cases, high concentrations of metal stimulate ubiquitination and endocytosis of the cell surface transporter and targeting to the vacuole for degradation. The Smf1p and Smf2p transporters can contribute to metal ion toxicity (Liu et al., 1997) , and recently cadmium has been shown to promote endocytosis of Smf1p through Rsp5p-dependent ubiquitination of specific lysine residues in the N-terminus (Nikko et al., 2008) . The regulation of Smf1p by cadmium was mediated by several arrestin-like proteins that appear to function as Rsp5p adaptors. However the regulation of Smf1p by cadmium appeared distinct from previously reported regulation of this transporter, because endocytosis was not observed when cells were stressed with manganese (Nikko et al., 2008) , and additional down-regulation of Smf1p and Smf2p in response to manganese toxicity has not been previously reported.
In this study, we have examined the fate of the Smf1p manganese transport protein in response to manganese starvation, physiological manganese, and manganese toxicity. We report here that in addition to the "basal" down-regulation of Smf1p during physiological manganese, an additional tier of Smf1p down-regulation occurs when cells are subject to very high doses of the metal. Loss of Smf1p at toxic manganese is distinct from Bsd2p-dependent regulation of the protein, but nevertheless does involve vacuolar degradation through the MVB pathway. We observe that sensing of manganese for regulating Smf1p at very low and very high metal levels requires distinct intracellular pools of the metal.
MATERIALS AND METHODS

Plasmids, Strains, and Growth Conditions
The majority of yeast of strains used in this study were derived from BY4741 (Mata, leu2⌬0, met15⌬0, ura3⌬0, his3⌬1) . Single gene deletions strains in the BY4741 background including bsd2⌬ ::kanMX4, tul1⌬::kanMX4, pmr1⌬::kanMX4, and mam3⌬::kanMX4 were obtained from Research Genetics (Huntsville, AL). The BSD2 gene was deleted in the indicated kanMX4 disruption strains using the bsd2⌬::HIS3 deletion plasmid (Liu et al., 1997) resulting in LJ385 (bsd2⌬::HIS3 vps21⌬::kanMX4) , LJ386 (bsd2⌬::HIS3 snf7⌬::kanMX4) , LJ387 (bsd2⌬::HIS3 vps36⌬:: kanMX4) , LJ388 (bsd2⌬::HIS3 pep4⌬::kanMX4) , LJ389 (bsd2⌬::HIS3 vps4⌬::kanMX4) , LJ390 (bsd2⌬::HIS3 vps23⌬::kanMX4) , LJ391 (bsd2⌬::HIS3 vps27⌬::kanMX4) , LJ392 (bsd2⌬::HIS3 end3⌬::kanMX4), LJ393 (bsd2⌬::HIS3 vps45⌬::kanMX4) , LJ395 (bsd2⌬:: HIS3 pep12⌬::kanMX4), LJ404 (bsd2⌬::HIS3 apm3⌬::kanMX4), LJ405 (bsd2⌬::HIS3 atg1⌬::kanMX4), LJ424 (pRSP5⌬::HIS3), LJ426 (bsd2⌬::kanMX4, pep4⌬, pRSP5⌬:: HIS3) . Additional strains used include BY4742 (Mat␣, leu2⌬0, lys2⌬0, ura3⌬0, his3⌬1) , the tre1/2⌬ strain (Mat␣, leu2⌬0, lys2⌬0, ura3⌬0, his3⌬1, tre1⌬, tre2⌬::kanMX4; Stimpson et al., 2006) , LJ420 (tre1/2⌬ bsd2⌬::HIS3), and LJ423 (BY4742 bsd2⌬::HIS3), LJ431 (his3, trp1, lys3, ura3, leu2, bar1, bsd2⌬::LEU2) , LJ432 (his3, trp1, lys3, ura3, leu2, bar1, bsd2⌬::LEU2) isogenic to LHY291 and LHY23, respectively (Dunn and Hicke, 2001 ) and the sod1⌬ bsd2⌬ smf1-1 strain XBSBS1 (Liu et al., 1997) . Yeast transformations were performed using the lithium acetate procedure (Gietz and Schiestl, 1991) . Cells were propagated at 30°C unless otherwise specified either in enriched yeast extract, peptone-based medium supplemented with 2% glucose (YPD), synthetic complete (SC) medium (Sherman et al., 1978) or in a metal-depleted minimal defined medium prepared through use of an ion exchange resin (Dancis et al., 1990) .
Plasmids pSF4 (SMF1), pSF6 (SMF2), and pMP043 (SMF3) expressing hemaglutinin (HA)-tagged versions of Smf1p, Smf2p, and Smf3p have been described previously (Liu and Culotta, 1999a,b; Portnoy et al., 2000) . In all cases, the HA tag is placed at the C-terminus. Point mutations in SMF1 were generated using pSF4 (Smf1-HA) as a template resulting in plasmids D92GpSF4, N95TpSF4, and E344ApSF4. The SMF1 promoter lacZ fusion plasmid was constructed using a derivative of pSF4 with a BamHI site immediately after the start codon. The SMF1 promoter was excised as an XhoI to BamHI fragment and ligated into the ß-galactosidase reporter plasmid pLG⌬178 (Guarente and Mason, 1983 ) cut with the same enzymes generating plasmid pLJ389 (containing SMF1 sequences Ϫ296 to ϩ 1). The GFP-Smf1 plasmid was a generous gift from Hugh Pelham (MRC Laboratory of Molecular Biology) and expresses a N-terminal GFP-Smf1 fusion in YCplac33 (CEN URA3) using the TPI1 promoter (Sullivan et al., 2007) . To generate N-terminal GFP fusions of SMF2 and SMF3 driven by the TPI1 promoter, SMF1 was excised from the GFP-SMF1 plasmid with BamHI and XbaI and replaced with SMF2 or SMF3 resulting in plasmids pLJ433 (GFP-SMF2) and pLJ434 . A N-terminal truncation of SMF1 was also generated in GFP-Smf1 by introducing a BamHI site at codon 63 followed by digestion with BamHI and religating resulting in plasmid pLJ365. A K33, 34R derivative of GFP-Smf1 was generated by site-directed mutagenesis resulting in plasmid pLJ460. To express C-terminal GFP fusions of FUR4 and TAT2 driven by the PGK1 promoter, FUR4 (Ϫ19 to ϩ 1899) and TAT2 (Ϫ17 to ϩ 1776), sequences were PCR amplified using Pfu polymerase introducing 5Ј SpeI or XbaI sites respectively, and replacing the stop codons with NotI sites. The PCR products were digested with the appropriate enzymes and ligated into plasmid pLJ457, a derivative of pAA1 (Hobbs et al., 2001) but containing a GFP fusion with PHO84 driven by the PGK1 promoter with a URA3 selectable marker, digested with XbaI/NotI, replacing the PHO84 sequences with those for either FUR4 or TAT2, resulting in plasmids pLJ458 and pLJ459, respectively. The RSP5 promoter disruption plasmid pLJ461 was generated by PCR, amplifying upstream (Ϫ916 to Ϫ468) and downstream sequences (Ϫ9 to ϩ508) of RSP5, introducing XbaI and EcoRI (upstream) or SacI and XbaI (downstream) restriction sites. After digestion the PCR products were ligated into pRS403 (HIS3; Sikorski, 1989) cut with SacI and EcoRI. All mutations were generated using the QuickChange mutagenesis kit (Stratagene, La Jolla, CA), and the sequence integrity of plasmids was ensured by double-stranded DNA sequencing (DNA Analysis Facility, Johns Hopkins University).
Immunoblots
Cultures were grown aerobically in either YPD or in minimal defined medium depleted of manganese that was supplemented as needed with MnCl 2 . Cultures were innoculated at an OD 600 nm of 0.2 and grown for 16 h or grown to an OD 600 nm of ϳ1 before addition of MnCl 2 . Yeast extracts were generated with the glass bead lysis protocol (Lapinskas et al., 1996) using 10 mM NaH 2 PO 4 , 1% Triton X-100, 50 mM NaCl, 5 mM EDTA, 5 mM EGTA, pH 7.8, containing protease inhibitors. Proteins were separated by SDS-PAGE using 12% gels, and immunoblots were probed with either anti-HA (Roche, Indianapolis, IN), anti-GFP (Molecular Probes, Eugene, OR), or anti-Pgk1 (Molecular Probes) antibodies at a 1:5000 dilution. Visualization of immunoblots utilized either HRP-conjugated secondary antibodies with ECL detection (Amersham Pharmacia Biotech, Piscataway, NJ) or the Odyssey infrared imagining system (Li-Cor Biosciences, Lincoln, NE) employing an Alexa Fluor 680 secondary antibody (Invitrogen, Carlsbad, CA). Quantitation of immunoblots utilized Odyssey quantitation software (version 1.2).
ß-Galactosidase Assays
Yeast transformants expressing either the pSMF1 or pACT1 LacZ reporter constructs were grown in YPD medium and ß-galactosidase activities were assayed using o-nitrophenyl ß-d-galactopyranoside as a substrate as previously described (Portnoy et al., 2002) . Results from two independent transformants assayed at least in duplicate were reported in Miller units (Giacomini et al., 1992) .
Fluorescence Imaging
Cells expressing the green fluorescent protein (GFP)-SMF fusion were imaged essentially as described (Sundin et al., 2004) . A pad of 1% low melting agarose (United States Biological , Swampscott, MA) in YPD was generated by placing 40 l of the melted agarose on a microscope slide and by compressing with a second slide. After agarose solidification and removal of the compressing slide, ϳ5 ϫ 10 4 cells were placed on the pad and covered with a coverslip. Fluorescence was viewed directly with either a Zeiss Axioplan upright microscope (Thornwood, NY; The Johns Hopkins Integrated Imaging Center) or a Nikon Eclipse TE300 equipped with a digital monochrome cameras (Melville, NY) at 100ϫ magnification.
RESULTS
The Down-Regulation of Smf1p by Toxic Manganese
Smf1p is known to respond to the switch from manganese starvation to physiological manganese by degrading much of the newly synthesized protein in the vacuole (Liu et al., 1997; Liu and Culotta, 1999b; Eguez et al., 2004; Hettema et al., 2004; Stimpson et al., 2006; Sullivan et al., 2007) . In addition to this well-defined pathway of Smf1p degradation under physiological manganese conditions, we now show that Smf1p is subject to down-regulation by toxic manganese. These two stages of Smf1p regulation are shown in Figure 1A . The abundance of Smf1p tagged at the N-terminus with GFP ("GFP-Smf1") is high in manganese-deficient medium compared with growth in the same minimal medium supplemented with 20 M manganese ( Figure 1A , left, cf. lanes 1 and 2). Adding increasing levels of manganese up to 5 mM does not change GFP-Smf1 levels, nor does the metal cause substantial toxicity over these several orders of magnitude concentrations ( Figure 1A , cf. lanes 2-7 and total growth bars below). We refer to this large range of nontoxic metal concentrations as "physiological" manganese. Yet when manganese in the growth medium becomes toxic to the cell, GFP-Smf1 levels are further decreased ( Figure 1A , lanes 8 and 9). The down-regulation of Smf1 by toxic manganese is not medium specific and also occurs in enriched medium, the only difference being the effective dose. The toxic dose of manganese is much lower in enriched medium, as cells are far more efficient at accumulating the metal from enriched medium, perhaps because of formation of extracellular manganese-phosphate complexes . As seen in Figure 1B , lanes 1-3, the level of a Smf1p tagged at the C-terminus with HA "Smf1-HA" from cells grown in enriched medium drops significantly as manganese levels begin to inhibit growth (see total growth bars below), and the same regulation at toxic manganese was observed with GFP-Smf1 ( Figure 1C , lane 2).
The effect of high manganese on Smf1p does not reflect nonspecific growth inhibitory effects of metals. In Figure 1B , lanes 6 -8 cells were treated with concentrations of cobalt, zinc, and copper that similarly inhibit total cell growth by Ϸ50% over a period of 16 h. Only manganese caused loss of Smf1-HA; if anything, copper treatment increased levels of Smf1-HA (lane 8), through an unknown pathway. We also tested whether the regulation of Smf1p by toxic manganese involves the Bsd2p and Tre1/Tre2 proteins implicated in Smf1-regulation by physiological manganese (Liu et al., 1997; Stimpson et al., 2006) . As seen in Figures 1, A (right) and C, regulation of GFP-Smf1 by toxic manganese is preserved in a bsd2⌬ strain. The same is true of GFP-Smf1 expressed in a triple bsd2⌬ tre1⌬ tre2⌬ strain ( Figure 1C ). Hence, regulation of Smf1p at very high manganese is distinct from regulation by low manganese in that it does not involve Bsd2p and the Tre1 and Tre2 proteins.
Toxic manganese regulation of Smf1p occurs independent of the gene promoter. SMF1 exhibits manganese regulation when driven by either its native promoter (sequences from Ϫ296; Figure 1B ) or the nonnative TPI1 promoter ( Figure  1C) . Moreover, when SMF1 promoter sequences were fused to LacZ, there was no down-regulation of promoter activity by high manganese (Figure 2A ). SMF1 is not transcriptionally regulated by toxic manganese, and we therefore examined posttranscriptional effects. The Bsd2p-dependent regulation of Smf1p occurs through vacuolar degradation (Liu and Culotta, 1999b) , and we tested whether the same was true for Bsd2-independent regulation. GFP-Smf1 protein levels were monitored in a bsd2⌬ strain also containing a pep4⌬ mutation blocking vacuolar proteases. As seen in Figure 2B , down-regulation of GFP-Smf1 by toxic manganese was inhibited in the bsd2⌬ pep4⌬ strain. By comparison, mutants that affect endoplasmic reticulum-associated degradation (ERAD) via the proteosome had no effect on toxic manganese regulation of GFP-Smf1 (Supplemental Figure  S1 ). Visualizing GFP-Smf1 in the bsd2⌬ pep4⌬ strain clearly shows GFP-Smf1 localization changing from a combination of plasma membrane and vesicular localization under physiological manganese to accumulation in the vacuole in the presence of toxic manganese ( Figure 2C ). Hence regulation by both physiological (Bsd2p-dependent) and toxic manganese (Bsd2p-independent) involves targeting of the protein to the vacuole for degradation.
Three pathways for vacuolar targeting in yeast involve trafficking through multivesicular bodies (MVB), autophagy, and the pathway used by alkaline phosphatase (ALP; reviewed in Huang et al., 2007 and references therein) . To test which if any of these were involved in toxic manganese regulation of Smf1p, we created double bsd2⌬ vps4⌬ (blocking the MVB pathway), bsd2⌬ atg1⌬ (blocking autophagy), and bsd2⌬ apm1⌬ (blocking ALP) mutants. As seen in Figure  2D , toxic manganese regulation was prevented by a vps4⌬ mutation in the MVB pathway, but not by mutants affecting autophagy or trafficking of ALP. An inspection of GFP-Smf1 localization in a bsd2⌬ vps4⌬ strain yielded a large punctate staining pattern reminiscent of class E compartments (Supplemental Figure S2 ) that are hallmarks of a block in trafficking through the MVB pathway (Raymond et al., 1992) . Therefore as is the case with Bsd2-dependent regulation of Smf1p (Hettema et al., 2004; Sullivan et al., 2007) , Bsd2-independent regulation at toxic manganese involves trafficking to the vacuole through the MVB.
To verify that the enhanced stability of Smf1p in the presence of toxic manganese was not specific for vps4⌬ cells, we examined GFP-Smf1 levels in additional mutants containing blocks in the MVB pathway. Key elements of the MVB pathway are the ESCRT complexes that sort proteins destined for the vacuole into endosomes and the MVB (Liu and Culotta, 1999b) and supplemented where indicated with the indicated concentration of MnCl 2 (M). GFP-Smf1 levels were assayed using immunoblots, and Pgk1p was monitored as a loading control (top panels) with total growth assayed using the optical density of cultures (OD 600 nm; bottom panels). ( Williams and Urbe, 2007) . We observed that blocking each of the ESCRT complexes individually using vps23⌬ (ESCRT-I), vps36⌬ (ESCRT-II), and snf7⌬ (ESCRT-III) mutations in combination with bsd2⌬ resulted in enhanced stability of GFPSmf1 grown with exposure to toxic manganese ( Figure 3A) . In addition to the ESCRT complexes we monitored GFPSmf1 levels in bsd2⌬ yeast lacking genes involved in entry of proteins into (PEP12 and VPS21; Gerrard et al., 2000a,b) or exit from (VPS27) the prevacuolar compartment (Piper et al., 1995) , and again we observed a block in the manganeseinduced degradation of Smf1p ( Figure 3B ). Localization of GFP-Smf1 in the bsd2⌬ vps27⌬ strain with toxic manganese is also consistent with a large endosome structure, most likely the class E compartment (Supplemental Figure S2 ). These results demonstrate that the MVB pathway is involved in targeting of Smf1p to the vacuole in cells grown in the presence of toxic manganese.
Smf1p has been localized to both the plasma membrane and in internal vesicles (Liu and Culotta, 1999b; Sullivan et al., 2007) . To determine if vacuolar targeting during manganese exposure involves one or both of these Smf1p locations, we utilized mutants that either blocked the endocytic pathway (end3⌬; Benedetti et al., 1994) or Golgi-to-vacuolar trafficking (vps45⌬; Bryant et al., 1998) . We observed that blocking either endocytosis or Golgi to vacuolar transport was capable of inhibiting some degradation of Smf1p during exposure to toxic manganese ( Figure 3C ), yet effects of blocking Golgi to vacuolar transport were greater than that of blocking endocytosis (see legend Figure 3C ). These results suggest that the Bsd2-independent vacuolar targeting of Smf1p largely involves protein derived from the exocytic pathway, but also from the endocytic pathway.
Two Steps for Down-Regulating Smf1 by Toxic Manganese
The aforementioned studies with secretory pathway mutants suggests that both cell surface and intracellular Smf1p are subject to down-regulation by toxic manganese. In wildtype (WT) cells, steady-state Smf1p is predominantly intracellular, whereas in bsd2⌬ mutants and also tre1 tre2 mutants, the protein can accumulate at the cell surface (Liu and Culotta, 1999b; Stimpson et al., 2006; Sullivan et al., 2007 ; also see Figure 4B ). We therefore analyzed Smf1p levels and localization in WT versus bsd2⌬ cells as a function of time of manganese treatment. The experiments of Figures 1-3 were all conducted with long-term "chronic" manganese exposures (16 h). Yet we observed that the addition of toxic manganese to WT cells has no effect during short periods and requires 4 h to see any change in GFP-Smf1; even so Smf1p loss is no greater than 50% ( Figure 4A, lane 7) . By comparison, the response of GFP-Smf1 in bsd2⌬ cells to toxic manganese is more rapid and GFP-Smf1 levels are reduced The abundance of GFP-Smf1 was monitored using immunoblots. (C) Cellular localization of GFP-Smf1 was observed by fluorescence microscopy at 100ϫ magnification. Strains utilized include WT, BY4741; bsd2⌬, 5738; bsd2⌬ pep4⌬, LJ388; bsd2⌬ vps4⌬, LJ389; bsd2⌬ atg1⌬, LJ405; and bsd2⌬ apm3⌬, LJ404. to ϳ20% within 2 h ( Figure 4A , right). The differences seen in the rate of loss of GFP-Smf1 between WT and bsd2⌬ yeast may be due to GFP-Smf1 localization. In WT cells, addition of toxic manganese does not significantly alter the punctate localization until 4 h of exposure when GFP-Smf1 begins to localize to the large round vacuoles ( Figure 4B, top panel) . In contrast, the effects of manganese on cell surface GFP-Smf1 in bsd2⌬ cells is more rapid. Within 30 min of manganese treatment, plasma membrane GFP-Smf1 begins to be endocytosed and is fully internalized by 3 h ( Figure 4B , bottom panel), and the same is true for GFP-Smf1 expressed in the tre1⌬ tre2⌬ and bsd2⌬ tre1⌬ tre2⌬ triple mutants ( Figure 4C ). However, the internalized Smf1p does not appear to immediate concentrate within the large round vacuole; this requires prolonged exposures to the metal (Ͼ4 h as in Figure  2C ). Hence, toxic manganese appears to affect Smf1p localization in two ways. First, there is a relatively rapid internalization of cell surface Smf1p as seen in bsd2⌬ mutants, and second, intracellular Smf1p as accumulates in WT cells, moves toward to the vacuole during prolonged exposures to the metal.
We tested whether these dual effects of manganese can be expanded to other transporters. Saccharomyces cerevisiae Smf2p transports manganese, whereas Smf3p is the vacuolar transporter of iron (Portnoy et al., 2000; Luk and Culotta, 2001 ). As seen in Figure 5A (lanes 3 and 4) , Smf2-HA expressed from its native promoter is not normally downregulated during chronic exposures to toxic manganese. However, Smf2p is expressed at very low levels compared with Smf1p (cf. lanes 1 and 3, Figure 5A ) and when placed under control of the strong TPI1 promoter, Smf2p did exhibit some toxic manganese regulation, but effects were only seen during chronic ( Figure 5B , lanes 3 and 4, bottom panel), and not short-term (top panel) exposures to manganese. Smf2p may have some capacity to respond to toxic manganese, but only when expressed at nonphysiological high levels. Compared with Smf1p and Smf2p, Smf3p is not regulated by manganese under any conditions tested, either driven by its own promoter ( Figure 5A , lane 6) or the TPI1 promoter ( Figure 5B , lane 6). We also tested the effects of manganese on the uracile permease Fur4p and the tryptophan/tyrosine permease Tat2p. The abundance of both Fur4-GFP and Tat2-GFP are not significantly changed by growth in the presence of toxic manganese ( Figure 5B ). Toxic manganese preferentially down-regulates Smf1p.
Previous studies have shown that regulation of Smf1p by physiological manganese (Stimpson et al., 2006) or by cadmium (Nikko et al., 2008) involves ubiquitination by the E3 ligase Rsp5p; we tested whether the same was true for toxic manganese regulation. To monitor the effects of rsp5 we first used a temperature-sensitive rsp5-1 allele. As seen in Figure  6A , the manganese-induced endocytosis of GFP-Smf1 in the bsd2⌬ strain was attenuated by the rsp5-1 mutation at the restrictive temperature. To test the effects of RSP5 loss at longer chronic periods of manganese toxicity, we used a viable promoter mutant of rsp5. In this allele, the HIS3 gene was inserted in the RSP5 promoter to causes a dramatic reduction in Rsp5p levels; this mutant is similar to other RSP5 promoter mutants containing insertion of a Ty element 1 and 8) or the same medium supplemented with 200 M MnCl 2 (16 h, lanes 2 and 9). Cultures were also grown in YPD to an OD 600 nm of ϳ1 and then supplemented with 200 M MnCl 2 (lanes 3-7 and 10 -14), and samples were removed at the indicated times after addition of manganese for immunoblot analysis. (B) Cellular localization of GFP-Smf1 was monitored using fluorescence microscopy at ϫ100 magnification. (C) GFP-Smf1 protein levels and cellular localization in bsd2⌬, tre1⌬ tre2⌬, and bsd2⌬ tre1⌬ tre2⌬ strains were monitored in cells grown in YPD as described in A and B. Strains utilized include WT, BY4741; bsd2⌬, 5738, bsd2⌬, LJ423; tre1⌬ tre2⌬, tre1/2; and bsd2⌬ tre1⌬ tre2⌬, LJ420. ( Hein et al., 1995) or the natMX cassette (Nikko et al., 2008) . This mutant is indeed defective for Rsp5p because basal levels of GFP-Smf1 were increased in this rsp5 mutant (Figure 6C , lanes 5 and 13) to the same degree as seen in a bsd2⌬ null (lanes 3 and 11), demonstrating a block in Smf1p regulation by physiological manganese. Moreover, this rsp5 promoter mutant mirrored the ts rsp5-1 allele in that it inhibited manganese-induced endocytosis of Smf1p in bsd2⌬ strains ( Figure 6B ). This viable rsp5 mutant provided the added advantage of monitoring effects at prolonged manganese exposures. As seen in Figure 6C , lane 14, the GFP-Smf1 polypeptide was still down-regulated Ϸ70% during chronic exposure of the rsp5 mutant to toxic manganese. Hence, Rsp5 appears necessary for manganese-induced endocytosis of Smf1p, but may not be as critical for vacuolar degradation of intracellular Smf1p during longer exposures to the metal.
To this end, we tested whether the Tul1p E3 ligase may be required. As seen in Figure 6C , tul1⌬ mutations had no effect on the down-regulation of Smf1p during chronic exposures to manganese (lane 16), implying an alternative mechanism.
The Smf1p N-Terminus and Toxic Manganese Regulation
We sought to determine sequences of Smf1p that modulate regulation during manganese toxicity. Smf1p and Smf2p contain N-terminal extensions that are absent in Smf3p, and in the case of Smf1p, residues K33 and K34 within this N-terminus were found to be involved in Smf1p regulation by cadmium (Nikko et al., 2008) . Specifically these residues were implicated in Rsp5p-mediated ubiquitination of Smf1p as a prelude to endocytosis (Nikko et al., 2008) . We tested whether these same residues were involved in toxic manganese regulation of Smf1p. As seen in Figure 7A , lane 7, the K33,34R variant of GFP-Smf1 was degraded to a degree similar to that of WT GFP-Smf1 under chronic (16 h) exposures to manganese. Moreover, under shorter periods of manganese toxicity, the protein was endocytosed ( Figure  7B ) and degraded ( Figure 7A , lanes 2-5) with roughly the same kinetics as WT GFP-Smf1. Although these N-terminal lysines are not absolutely essential for manganese regulation, we did observe a requirement for the Smf1p N-terminus. As seen in Figure 7A , a ⌬63 variant of GFP-Smf1 lacking the cytosolic N-terminus was not down-regulated during 4 h of manganese treatment (lanes 2-5), nor was the protein subject to any endocytosis during this period ( Figure 7B ). Nevertheless, ⌬63 GFP-Smf1 did eventually exhibit some down-regulation by toxic manganese during chronic exposures ( Figure 7A , lane 7, middle panel). The N-terminus appears to facilitate the rapid response to toxic manganese, and residues other than K33 and K34 are involved.
Sensing of Manganese for Regulating Smf1p by Manganese Starvation versus Manganese Toxicity
An attractive model for the manganese regulation of Smf1p involves Smf1p as a sensor itself whereby metal binding to the transporter signals targeting to the vacuole for degradation. To begin to address this, we tested whether metal transport activity was necessary for the regulation of Smf1p during chronic manganese toxicity.
Previous mutagenesis studies with bacterial and human Nramp transporters have identified conserved residues important for metal ion transport. On the basis of these findings, we introduced mutations D92G and E344A into TM1 and TM8 of Smf1-HA, whose equivalent substitutions in human Nramp2 disrupt metal transport without affecting protein localization (Lam-Yuk-Tseung et al., 2003) . We also introduced N95T into Smf1p TM1, which was shown to disrupt manganese transport in Escherichia coli Nramp (Chaloupka et al., 2005) . All three Smf1-HA mutants were stably expressed in yeast ( Figure 8B ), yet were unable to complement the oxidative stress defect of a yeast smf1 mutant ( Figure 8A ), a phenotype specifically associated with loss of Smf1p-manganese transport (Reddi et al., 2009) . Hence, these mutants are defective in Smf1-manganese transport in yeast. Nevertheless the three transport mutants were still down-regulated by chronic exposure to toxic manganese ( Figure 8B , top panel), demonstrating that manganese transport is not necessary for this response to metal toxicity. We also tested whether the transport mutants affect the ability of Smf1p to respond to manganese starvation. WT Smf1-HA levels are normally increased during manganese starvation (Liu and Culotta, 1999b) as seen in Figure 8B (bottom panel, lane 2). However, all three manganese transport mutants were impaired in their ability to respond to changes in manganese starvation conditions ( Figure 8B bottom panel). Smf1p mutants D92G and N95T fail to be upregulated with manganese starvation as was seen with other mutants that disrupt manganese transport (Liu and Culotta, 1999b) . Levels of the E344A mutant also do not change with manganese starvation, although this Smf1p variant accumulates to overall higher levels. Smf1p transport activity seems important for regulation by very low, but not very high manganese.
What are the pools of manganese that are being sensed for Smf1p regulation? Because Smf1p localizes at both the cell surface and secretory pathway, Smf1p regulation could involve manganese pools that are extracellular, cytosolic, or intraluminal secretory pathway. To begin to resolve this, we tested Smf1p regulation in yeast mutants affecting manganese homeostasis. We have previously shown that yeast mam3⌬ mutants accumulate lower cytosolic manganese under manganese surplus conditions and are resistant to manganese toxicity . As seen in Figure 9A , it takes greater concentrations of manganese to down-regulate Smf1-HA in a mam3⌬ mutant compared with the WT strain. Because it is intracellular and not extracellular manganese that is affected in mam3⌬ mutants , Smf1-HA is responding to an intracellular pool of toxic manganese during chronic manganese toxicity. Another mutant affecting cellular pools of manganese is pmr1. PMR1 encodes a Golgi transporting ATPase for Mn. Mutants lacking Pmr1p accumulate high manganese in the cytosol and low Golgi manganese, and are exquisitely sensitive to manganese toxicity (Rudolph et al., 1989; Lapinskas et al., 1995; Durr et al., 1998; Mandal et al., 2000) . As seen in Figure 9B , pmr1⌬ mutants down-regulate Smf1-HA at much lower manganese concentrations than the WT strain. As such, Figure 8 . Effects of metal transport mutations on manganese regulation of Smf1p. (A) The ability of the indicated Smf1-HA mutants or WT Smf1-HA to complement a smf1-1 mutation was tested. A sod1⌬ bsd2⌬ smf1-1 is unable to grow aerobically without lysine because of loss of Smf1p-transport of manganese-based antioxidants, which substitute for Cu/Zn SOD1 (Reddi et al., 2009) . Transformation with WT Smf1 complements this defect and allows for aerobic growth on medium lacking lysine (left), whereas the corresponding Smf1p mutants do not. (B) Smf1-HA and the D92G, N95T, and E344A derivatives were expressed in the WT BY4741 strain and protein abundance was monitored using immunoblots. Smf1p appears to sense cytosolic or extra Golgi manganese during chronic manganese toxicity.
We also used the pmr1⌬ mutant to test whether cytosolic or Golgi luminal manganese is being sensed with manganese starvation. In WT cells, Smf1-HA is normally expressed at high levels with manganese starvation, and down-regulated in response to 5-10 M (nontoxic/physiological) levels of manganese ( Figure 9C ). Yet in a pmr1⌬ mutant, there is no such response to manganese; the polypeptide remains at high levels ( Figure 9C ). Because a pmr1⌬ mutant blocks manganese uptake into the secretory pathway, these studies indicate that under manganese starvation conditions, Smf1p is sensing intraGolgi manganese. Hence, the manganese for regulating Smf1p at manganese starvation and chronic manganese toxicity appears to arise from different cellular compartments.
DISCUSSION
Yeast cells respond to differential manganese exposures by altering the polypeptide levels and localization of the major Nramp manganese transporter Smf1p. Under manganese starvation, the transporter stably accumulates at the cell surface, whereas with physiological manganese, a bulk but not all of the protein is degraded in the vacuole via the MVB pathway. We now show that under manganese toxicity conditions, the remainder of Smf1p is also targeted to the MVB for vacuolar degradation, but through a distinct mechanism.
As we show for Smf1p, the Ftr1p iron transporter of yeast also undergoes two tiers of vacuolar degradation (Strochlic et al., 2008) . With physiological iron, Ftr1p is subject to "basal MVB sorting" and with higher iron levels, a "stimulated MVB sorting" occurs where a larger proportion of the transporter is degraded (Strochlic et al., 2008) . Both basal and stimulated MVB sorting of Ftr1p employ the same pathway involving ubiquitination by the E3 ligase Rsp5p (Strochlic et al., 2008) . Although Smf1p is similarly subject to basal and stimulated MVB sorting, distinct pathways are utilized. Basal MVB sorting with physiological manganese clearly involves recognition by Bsd2p/Tre1p/Tre2p, whereas stimulated MVB sorting at high manganese does not. Furthermore, basal MVB sorting of Smf1p clearly requires ubiquitination by Rsp5p, whereas a role for Rsp5p in stimulated MVB sorting of Smf1p is less obvious. Our studies thus far suggest that Rsp5p is required for manganese-induced endocytosis of Smf1p, but may not be required for ultimate delivery of Smf1p to the vacuole. However, since the rsp5 mutants used in these studies are not nulls, we cannot totally exclude the possibility that a low level of Rsp5p is sufficient to trigger vacuolar targeting of Smf1p during manganese toxicity. In any case, the lack of a requirement for Bsd2p and Tre1/Tre2 demonstrate that basal and stimulated MVB targeting of Smf1p are distinct. The need for dual pathways may reflect the second Nramp transporter, Smf2p. Smf2p is subject to the same basal MVB, Bsd2p-mediated degradation as Smf1p (Portnoy et al., 2000) , but is not typically turned over with toxic manganese. Smf2p is critical for activating manganese enzymes in the cell (Luk and Culotta, 2001 ) and the use of a Bsd2-independent pathway for regulating Smf1p during toxic manganese may help keep Smf2p levels constant.
Proteins can enter the MVB through either endocytic (from cell surface) or exocytic (from Golgi) pathways. Our studies show that both pathways can contribute to Smf1p degradation during manganese toxicity, but the kinetics for the two are different. In the case of cell surface Smf1p that accumulates in bsd2⌬ strains, treatment with toxic manganese can trigger complete endocytosis of the transporter within 1-3 h. But when steady-state Smf1p is largely intracellular, as with WT cells, the kinetics for vacuolar targeting are remarkably slow and require Ն4 h. Furthermore, the Smf1p that is endocytosed upon manganese treatment is not immediately targeted to the vacuole, but requires sustained metal exposures to reach the vacuolar lumen. It is possible that this endocytic Smf1p merges with exocytic Smf1p into the same "holding" pool of the transporter that is ultimately moved into the vacuole after prolonged periods of toxic manganese exposure. In any case, the kinetics are quite slow in comparison to other reports of vacuolar targeting of metal transporters. With yeast transporters for copper, zinc and iron, the response time for transporter endocyotsis and/or vacuolar targeting typically ranges from minutes to 2 h (Gitan and Eide, 2000b; Pena et al., 2000; Felice et al., 2005) . Moreover, cadmium was recently shown to induce endocytosis of Smf1p within minutes and vacuolar degradation within 1-2 h (Nikko et al., 2008) . The degradation of Smf1p by toxic manganese, particularly in WT cells is indeed very slow. The rationale for this slow response may be based on the role of Smf1p in oxidative stress protection. Exceedingly high levels of manganese that approach toxicity can provide a unique benefit to cells by promoting formation of nonproteinacous manganese antioxidants Fridovich, 1981, 1982; Chang and Kosman, 1989; Al-Maghrebi et al., 2002; Barnese et al., 2008) . In S. cerevisiae, Smf1p serves as the primary source of these manganese antioxidants (Reddi et al., 2009) , and therefore Smf1p can be both protective and detrimental in the face of high manganese. The immediate degradation of Smf1p during high manganese exposures may not always be advantageous.
Our studies with manganese accumulation mutants (i.e., pmr1 and mam3) show that during chronic manganese toxicity, intracellular, presumably cytosolic pools of the metal are being sensed for down-regulation of Smf1p. As one possibility, the metal directly reacts with Smf1p in the secretory pathway to stimulate its movement to the vacuole. The manganese translocating residues of the transporter are not likely to be involved, as Smf1p mutants defective in manganese transport were still subject to toxic manganese regulation. Other, perhaps low-affinity manganese binding sites on Smf1p may trigger trafficking to the vacuole. Alternatively, manganese binding to an as-of-yet unidentified partner protein for Smf1p may direct vacuolar targeting in the face of manganese toxicity.
Lastly, these studies have provided evidence for distinct modes of manganese sensing under very high and very low manganese. Our experiments with pmr1⌬ mutants disrupted for Golgi uptake of manganese indicate that under manganese starvation conditions, the cell senses intra-Golgi manganese for up-regulation of Smf1p. By comparison, manganese pools outside the secretory pathway, presumably cytosolic are being sensed for the strong down-regulation of Smf1p during long-term manganese toxicity. This separate compartmentalization for manganese sensing is logical when one considers the consequences of too much or too little manganese. During manganese starvation, the critical manganese sugar transferases of the Golgi are at risk for inactivation (Nakajima and Ballou, 1975; Parodi, 1979; Durr et al., 1998) . The cytosol on the other hand appears to be a prime target of manganese toxicity (Lapinskas, 1995; Durr et al., 1998) . The distinct compartmentalization for sensing extremes of metal starvation and metal toxicity are likely applicable to other transition metals that are both essential and potentially deleterious.
